Ciprofolxacin Suspension Suppliers & Bulk Manufacturers
Available Forms: Oral Suspension
Available Strengths: 100 mg/5 mL, 200 mg/5 mL
Reference Brands: Cipro(US & EU)
Category:
Antibiotics
Ciprofloxacin suspension inhibits bacterial DNA gyrase and topoisomerase IV, disrupting DNA replication and bacterial growth. It effectively treats urinary, respiratory, and gastrointestinal infections. Benefits include rapid absorption, broad-spectrum activity, and suitability for pediatric use, providing reliable, targeted infection control with convenient oral administration when used properly.
Ciprofolxacin Suspension is available in Oral Suspension
and strengths such as 100 mg/5 mL, 200 mg/5 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Ciprofolxacin Suspension is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Ciprofolxacin Suspension can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Ciprofloxacin suspension is approved in the EU and US for treating urinary, respiratory, and gastrointestinal infections, especially in pediatric patients. In the EU, brands like Cipro are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data, with generic formulations available. Both regions require detailed dossiers, including clinical trial results, manufacturing practices, and pharmacovigilance plans, for approval and ongoing safety monitoring. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support seamless market access for ciprofloxacin suspension, ensuring adherence to European and US standards for safe, effective antibiotic therapy.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing